Werewolf Therapeutics Appoints Mike Sherman to its Board of Directors

May 27, 2021

Over 30 years of experience in advancing therapeutics to commercial launch and driving companies to successful operations and strategic transactions.

January 13, 2025

Werewolf Therapeutics Provides Business Update and Highlights 2025 Strategic Outlook

WATERTOWN, Mass., January 13, 2025 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…... Read More

November 20, 2024

Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference

WATERTOWN, Mass., November 20, 2024 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)... Read More

November 7, 2024

Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

WATERTOWN, Mass., November 7, 2024 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)... Read More

Share this article: